INYANG MORRIS: Open Payments
NPI 1245822329 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 109 payments from 12 companies in 2025. Trend: 2023 $2,403 · 2024 $1,747 · 2025 $2,096
Food & beverage: $2,096
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 31 | $403 |
| ABBVIE INC. | 18 | $313 |
| E.R. Squibb & Sons, L.L.C. | 4 | $270 |
| Janssen Pharmaceuticals, Inc | 10 | $265 |
| Alkermes, Inc. | 12 | $227 |
| Neurocrine BioSciences, Inc. | 15 | $168 |
| Lundbeck LLC | 6 | $160 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
Products named: UZEDY, VRAYLAR, COBENFY, ARISTADA, ABILIFY ASIMTUFII, INGREZZA, SPRAVATO, INVEGA SUSTENNA.
Industry payments across TN — which companies pay providers there.
